SCHEMBL22006830

SCHEMBL22006830

COC(=O)c1oc2c(Cl)cccc2c1N

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.60
HPGD P15428 3/20 0.55
SMN1; SMN2 Q16637 3/20 0.55
ALDH1A1 P00352 2/20 0.55
TP53 P04637 1/20 0.48
HTT P42858 1/20 0.48
HSD17B10 Q99714 1/20 0.48
AHR P35869 1/20 0.46
MEN1 O00255 1/20 0.45
GAA P10253 1/20 0.45
KMT2A Q03164 1/20 0.45
RAB9A P51151 1/20 0.44
POLB P06746 1/20 0.44
NR4A2 P43354 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
ATM Q13315 1/20 0.43
NPSR1 Q6W5P4 1/20 0.42
MAPK1 P28482 1/20 0.42
ABL1 P00519 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25706649 0.87 MEN1 (0.57) KDM4EHPGDSMN1; SMN2MEN1GAA
SCHEMBL19024782 0.86 KDM4E (0.64) KDM4EALDH1A1HSD17B10AHRMEN1
SCHEMBL10394723 0.84 POLB (0.45) KDM4EHPGDSMN1; SMN2ALDH1A1MEN1
SCHEMBL24110905 0.80 MEN1 (0.48) KDM4EHPGDSMN1; SMN2MEN1GAA
SCHEMBL4338832 0.78 KDM4E (0.61) KDM4EHPGDSMN1; SMN2ALDH1A1TP53
SCHEMBL24110839 0.76 PLK1 (0.44) KDM4EMEN1GAAKMT2ARAB9A
SCHEMBL1885241 0.75 KDM4E (1.00) KDM4EHPGDSMN1; SMN2ALDH1A1TP53
SCHEMBL11233136 0.74 ATM (0.54) KDM4EHPGDSMN1; SMN2MEN1GAA
SCHEMBL10430027 0.72 KDM4E (0.66) KDM4EHPGDALDH1A1HSD17B10AHR
SCHEMBL1520571 0.72 MCL1 (0.71) KDM4EHPGDSMN1; SMN2ALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200161564-A1 ORGANIC COMPOUND, COMPOSITION, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200161564-A1 ORGANIC COMPOUND, COMPOSITION, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE OXER1, OR10J3, OCIAD1 KDM4E 4066/4885HPGD 3708/4885SMN1; SMN2 2012/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.